| Olivia G Herndon, FNP | |
|
225 Field St, New Bedford, MA 02740-2134 | |
| (508) 999-2981 | |
| (508) 910-3395 |
| Full Name | Olivia G Herndon |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 225 Field St, New Bedford, Massachusetts |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174182729 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 2306199 (Massachusetts) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Olivia G Herndon, FNP 225 Field St, New Bedford, MA 02740-2134 Ph: (508) 999-2981 | Olivia G Herndon, FNP 225 Field St, New Bedford, MA 02740-2134 Ph: (508) 999-2981 |
News Archive
AbbVie, a global biopharmaceutical company, today announced that results from a Phase 1b trial of investigational venetoclax, a novel inhibitor of the B-cell lymphoma-2 (BCL-2) protein that is being developed in partnership with Genentech and Roche, in combination with bortezomib and dexamethasone, showed an 83 percent overall response rate (n=5/6) in bortezomib-naive patients with relapsed/refractory (R/R) multiple myeloma, including two patients who achieved complete responses.1 These data will be presented at the American Society of Clinical Oncology (ASCO) Annual Meeting on Sunday, May 31, in Chicago.
A new method enables anisakids to be detected in any fish product, from a whole fish, fresh or frozen, to tinned fish and surimi. Developed by Spanish scientists, the system is based on molecular techniques and overcomes the limitations of traditional procedures.
Atrium Medical Corporation is pleased to announce that the final patient was recently enrolled in the iCAST™ Atrium Registry Ultrasound Study (iCARUS). This study is a prospective, multi-center clinical trial studying the safety and efficacy of the Atrium iCAST™ Balloon Expandable Covered Stent in patients with occlusive disease of the iliac artery.
Lowering one's blood pressure is beneficial not only for the heart, but also for the mind. For the first time, researchers have proved that lowering systolic blood pressure to 120 mm Hg or less reduces the risk of mild cognitive impairment, which in turn, reduces one's risk of developing Alzheimer's disease or dementia.
November is National Caregivers Month, a time to acknowledge the important role family and friends play in caring for their ailing and elderly family members. Aptly timed, the Rosalynn Carter Institute for Caregiving recently named David W. Coon, PhD, associate vice provost and professor in the College of Nursing & Health Innovation at Arizona State University, and his fellow experts the 2013 Rosalynn Carter Leadership in Caregiving Award.
› Verified 8 days ago
Vivian E Esswein, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 874 Purchase St, New Bedford, MA 02740 Phone: 508-992-6553 Fax: 508-990-7558 | |
Kveta Vojkovska, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 225 Field St, New Bedford, MA 02740 Phone: 508-910-3371 | |
Mrs. Lori Lee Georgeson, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 874 Purchase St, New Bedford, MA 02740 Phone: 508-992-6553 Fax: 508-984-8420 | |
Heather Goddard, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 874 Purchase St, New Bedford, MA 02740 Phone: 508-992-6553 Fax: 508-997-2498 | |
Amelia Elizabeth Monteiro, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 874 Purchase St, New Bedford, MA 02740 Phone: 508-992-6553 | |
Preeti Sharma, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 874 Purchase St, New Bedford, MA 02740 Phone: 508-992-6553 Fax: 508-984-8420 |